Join us.

Drug Discovery

Genetic Screening Scientist

With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.


The Role

We are looking for an enthusiastic and motivated lab-based drug discovery scientist to join our Cell Engineering and Genetic Screening group within the In Vitro Biology team. You will contribute to our technology-enabled drug discovery programmes, supporting programmes across the company’s portfolio. As a central member of a dynamic, multi-disciplinary team of scientists passionate about reinventing the way new medicines are developed, you will bring your understanding of in vitro genetic manipulation to support progression of drug discovery projects.

Primary Responsibilities

  • Develop and optimise relevant cell-based assays and perform screens using genetic approaches (siRNA, shRNA, CRISPR) to support pipeline projects
  • Generate cell lines (over-expressing, knock-out, mutated, reporter) to support our technology-enabled drug discovery programmes
  • Generate detailed SOPs and follow assay protocols
  • Critically analyse and interpret data, define realistic timelines for studies and meet delivery deadlines to execute high impact studies
  • Capture data using electronic lab books and databases such as Dotmatics
  • Write guidance documents

We are looking for someone with

  • BSc, MSc or equivalent experience in biological sciences or a closely related discipline. Industry research experience is preferred but not required.
  • Experience with siRNA, shRNA and CRISPR technologies
  • Experience with cell culture including primary and/or immortalised cells, hiPSC cells, organoid or 3D cultures
  • Experience with ELISA, Western Blotting, RT-qPCR, flow cytometry or high content imaging
  • Strong organisational and communication skills
  • Ability to work independently and also as part of a team
  • Experience with automation is preferred
  • We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey.  If that sounds like a fit for you, hit the apply button and join us.

    About us

    BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.

    Want to do a little more research before you apply?

    Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team thinks about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.

    Important Note

    Our team will only contact you from the domain If you receive a suspicious contact request, please email Thank you.